QP Cough Cold Tablets Recalled for Improper Storage Conditions
QP Cough Cold Tablet 16 CT units distributed to specific Family Dollar Stores nationwide are being recalled due to storage temperature deviations. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard—improper storage temperature—is a quality and regulatory compliance issue. Per the rubric, precautionary recalls without reported harm fall into the Moderate category.
Plain-English summary
QP Cough Cold Tablet 16 CT is being recalled by Family Dollar Stores, LLC due to Good Manufacturing Practice (CGMP) deviations. The product was held outside appropriate storage temperature conditions during distribution to consumers.
The affected product was distributed to specific Family Dollar Stores between April 30, 2022 and June 10, 2022 on a nationwide basis in the United States. The product is identified by SKU 916922.
Consumers who have purchased this product should stop using it. Anyone with questions or concerns may contact Family Dollar Stores, LLC. To date, no illnesses or injuries have been reported associated with this recall.
The recalled product
- Product
- QP COUGH COLD TABLET 16 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Cough/Cold Medication
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 916922
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27